top of page

Pharma Digital Health Commercial Assessment

Lupin Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 160 drugs in the United States.
Lupin is interested in entering the digital health / digital therapeutic sector
DTxCC conducts a commercial assessment to develop a clear understanding of the US marketplace and opportunities for a digital health/therapeutic offering
Go-to-market strategies
  • ROI/NPV Investment Evaluation
  • Incremental sales forecast
  • Supporting evidence/promotions needed for commercial success
  • Organizational capabilities needed for commercial success
bottom of page